Authors: Millot, F Suciu, S Philippe, N Benoit, Y Mazingue, F Uyttebroeck, A Lutz, P Mechinaud, F Robert, A Boutard, P Marguerite, G Ferster, A Plouvier, E Rialland, X Behard, C Plantaz, D Dresse, MF Philippet, P Norton, L Thyss, A Dastugue, N Waterkeyn, C Vilmer, E Otten, J

Citation: F. Millot et al., Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: Results of the European Organizationfor Research and Treatment of Cancer 58881 Randomized Phase III Trial, J CL ONCOL, 19(7), 2000, pp. 1935-1942

Authors: Mabro, M Cohn, R Zanesco, L Madon, E Hahlen, K Marguerite, G Breatnach, F Gentet, JC Plouvier, E

Citation: M. Mabro et al., Oral granisetron solution as prophylaxis for chemotherapy-induced emesis in children: double-blind study of two doses, B CANCER, 87(3), 2000, pp. 259-264

Authors: Ferster, A Benoit, Y Francotte, N Dresse, MF Uyttebroeck, A Plouvier, E Thyss, A Lutz, P Marguerite, G Behar, C Mazingue, F Boutard, P Millot, F Rialland, X Mechinaud, F Norton, L Robert, A Otten, J Vilmer, E Philippe, N Waterkeyn, C Suciu, S

Citation: A. Ferster et al., Treatment outcome in infant acute lymphoblastic leukemia, BLOOD, 95(8), 2000, pp. 2729-2730

Authors: Kayser, D Khodja, M Marguerite, G

Citation: D. Kayser et al., Delivery by a Tec 6 (TM) vaporizer of desflurane vapour above the dialled-in concentration., ANN FR A R, 18(6), 1999, pp. 691-693